Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies

YB Zhang, XF Pan, J Chen, A Cao, L Xia… - J Epidemiol …, 2021 - jech.bmj.com
Introduction Unhealthy lifestyles caused a huge disease burden. Adopting healthy lifestyles
is the most cost-effective strategy for preventing non-communicable diseases. The aim was …

Sex-specific cardiovascular risks of cancer and its therapies

NS Wilcox, SJ Rotz, MK Mullen, EJ Song… - Circulation …, 2022 - Am Heart Assoc
In both cardiovascular disease and cancer, there are established sex-based differences in
prevalence and outcomes. Males and females may also differ in terms of risk of cardiotoxicity …

[HTML][HTML] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

G Curigliano, D Lenihan, M Fradley, S Ganatra… - Annals of …, 2020 - Elsevier
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

Underdiagnosis and undertreatment of modifiable cardiovascular risk factors among survivors of childhood cancer

EJ Chow, Y Chen, GT Armstrong… - Journal of the …, 2022 - Am Heart Assoc
Background Determine the prevalence and predictors associated with underdiagnosis and
undertreatment of modifiable cardiovascular disease (CVD) risk factors (hypertension …

Allogeneic hematopoietic cell transplantation; the current renaissance

EA Copelan, A Chojecki, HM Lazarus, BR Avalos - Blood Reviews, 2019 - Elsevier
Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for
many patients with malignant and nonmalignant hematologic disorders. Recent advances in …

Cardiovascular complications in hematopoietic stem cell transplanted patients

Y Zhao, R He, S Oerther, W Zhou, M Vosough… - Journal of Personalized …, 2022 - mdpi.com
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for many
patients suffering from hematologic malignancies, solid tumors, inborn errors of metabolism …

Prediction of cardiovascular disease among hematopoietic cell transplantation survivors

SH Armenian, D Yang, JB Teh, LC Atencio… - Blood …, 2018 - ashpublications.org
Cardiovascular disease (CVD) is a leading cause of late morbidity and mortality in
hematopoietic cell transplantation (HCT) survivors. HCT-specific CVD risk prediction models …

Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation

SJ Rotz, TD Ryan, SS Hayek - Journal of thrombosis and thrombolysis, 2021 - Springer
Hematopoietic stem cell transplantation (HSCT) is a potentially curative treatment for many
malignancies, hemoglobinopathies, metabolic diseases, bone marrow failure syndromes …

Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation

GH Oliveira, SG Al-Kindi, A Guha, AK Dey… - Bone marrow …, 2021 - nature.com
The purpose of this review is to provide a framework for the cardiovascular evaluation and
management of patients undergoing hematopoietic cell transplantation (HCT). To …

Late effects after haematopoietic stem cell transplantation in ALL, long-term follow-up and transition: a step into adult life

T Diesch-Furlanetto, M Gabriel… - Frontiers in …, 2021 - frontiersin.org
Haematopoietic stem cell transplant (HSCT) can be a curative treatment for children and
adolescents with very-high-risk acute lymphoblastic leukaemia (ALL). Improvements in …